Surgery in Autoimmune Pancreatitis
Digestive Surgery · 2022 · 39 (1) · 32-41
DOI: 10.1159/000521490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Surgery, online erschienen am 15.12.2021. Verfasst von Sara Nikolic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Autoimmune Diseases, Autoimmune Pancreatitis, Pancreatic Neoplasms, Pancreatitis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Autoimmune pancreatitis (AIP) is a disease that may mimic malignant pancreatic lesions both in terms of symptomatology and imaging appearance. The aim of the present study is to analyze experiences of surgery in patients with AIP in one of the largest European cohorts. Patients and Methods: We performed a single-center retrospective study of patients diagnosed with AIP at the Department of Abdominal Diseases at Karolinska University Hospital in Stockholm, Sweden, between January 2001 and October 2020.
Results
There were 159 patients diagnosed with AIP, and among them, 35 (22.0%) patients had surgery: 20 (57.1%) males and 15 (42.9%) females; median age at surgery was 59 years (range 37–81). Median follow-up period after surgery was 50 months (range 1–235). AIP type 1 was diagnosed in 28 (80%) patients and AIP type 2 in 7 (20%) patients. Malignant and premalignant lesions were diagnosed in 8 (22.9%) patients for whom AIP was not the primary differential diagnosis, but in all cases, it was described as a simultaneous finding and recorded in retrospective analysis in histological reports of surgical specimens.
Conclusions
Diagnosis of AIP is not always straightforward, and in some cases, it is not easy to differentiate it from the malignancy. Surgery is generally not indicated for AIP but might be considered in patients when suspicion of malignant/premalignant lesions cannot be excluded after complete diagnostic workup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Gastroenterology, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
- Department of Clinical Science, Intervention, and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
- Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.
Zitieren
APA
Nikolic, S., Ghorbani, P., Pozzi Mucelli, R., Ghazi, S., Baldaque-Silva, F., Del Chiaro, M., Sparrelid, E., Verbeke, C. S., Löhr, J. M., & Vujasinovic, M. (2022). Surgery in Autoimmune Pancreatitis. Digestive Surgery, 39(1), 32-41. https://doi.org/10.1159/000521490
Vancouver
Nikolic S, Ghorbani P, Pozzi Mucelli R, Ghazi S, Baldaque-Silva F, Del Chiaro M, et al. Surgery in Autoimmune Pancreatitis. Digestive Surgery. 2022;39(1):32-41. doi:10.1159/000521490
BibTeX
@article{Nikolic2022,
author = {Nikolic, Sara and Ghorbani, Poya and Pozzi Mucelli, Raffaella and Ghazi, Sam and Baldaque-Silva, Francisco and Del Chiaro, Marco and Sparrelid, Ernesto and Verbeke, Caroline S and Löhr, J-Matthias and Vujasinovic, Miroslav},
title = {Surgery in Autoimmune Pancreatitis},
journal = {Digestive Surgery},
year = {2022},
volume = {39},
number = {1},
pages = {32--41},
doi = {10.1159/000521490}
}
EUVIMED